載入...
Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
Despite its good initial response and significant survival benefit in patients with castration-resistant prostate cancer (CRPC), taxane therapy inevitably encounters drug resistance in all patients. Deep understandings of taxane resistant mechanisms can significantly facilitate the development of ne...
Na minha lista:
| 發表在: | Acta Pharm Sin B |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6089846/ https://ncbi.nlm.nih.gov/pubmed/30109177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2018.04.007 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|